BeStock  
Stocks › Biotechnology › ORKA

Oruka Therapeutics ORKA

US equityMarket cap rank #1788Biotechnology
$95.81 −$1.76 (-1.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $95.81 0.00%
Open$95.86
Prev close$97.57
Day range$93.30 – $97.24
Volume1.98M
Market cap$6.50B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$62.14M-82.2% YoY
Net profit-$49.97M-65.0% YoY
Diluted EPS-$0.63-14.5% YoY
Free cash flow-$44.41M-104.6% YoY
Operating cash flow-$44.33M

Revenue, last 8 quarters

$0.0Sep '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-28.6MSep '24$-21.0MMar '25$-24.6MJun '25$-30.3MSep '25$-29.6MDec '25$-31.8MMar '26$-41.2MJun '26$-50.0MSep '26

Diluted EPS by quarter

-1.46Sep '24-0.40Mar '25-0.46Jun '25-0.55Sep '25-0.45Dec '25-0.48Mar '26-0.55Jun '26-0.63Sep '26

Free cash flow by quarter

$-11.0MJun '24$-20.9MMar '25$-23.2MJun '25$-21.7MSep '25$-22.7MDec '25$-23.7MMar '26$-33.1MJun '26$-44.4MSep '26

Profitability & balance sheet

Return on equity-18.2%
Return on assets-17.5%
Return on invested capital-21.7%
Current ratio29.62
Liabilities / assets2.8%
Cash & investments$920.28M
Total debt$2.09M
Net cash (debt)$918.18M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Net cash flow from investing -$159.40M -$410.95M -$14.44M -$22.02M -$96.75M
-Change in Other Current Liabilities -$156,000.00 -$138,000.00 -$125,000.00 $20,000.00 -$448,000.00
-Change in Other Current Assets $0.00 -$25,000.00 $0.00 $0.00 -$60,000.00
-Change in Payables and Accrued Expense $8.64M $6.35M $1.20M $4.16M $1.93M
-Change in Prepaid Assets -$10.22M -$4.64M $461,000.00 -$805,000.00 -$3.97M
Change in Working Capital -$1.73M $1.54M $1.53M $3.37M -$2.56M
Other Non-Cash Items -$1.81M -$806,000.00 -$303,000.00 -$524,000.00 -$4.55M
Depreciation & Depletion & Amortization $49,000.00 $43,000.00 $43,000.00 $28,000.00 $83,000.00
Net Income from Continuing Operations -$49.97M -$41.21M -$31.82M -$29.58M -$105.43M
Net cash flow from continuing operations -$44.33M -$33.15M -$23.58M -$22.59M -$88.21M
Operating Cash Flow -$44.33M -$33.15M -$23.58M -$22.59M -$88.21M
Net Cash Flow from Continuing Investing Activities -$159.40M -$410.95M -$14.44M -$22.02M -$96.75M
Net PPE Purchase and Sale -$83,000.00 $0.00 -$73,000.00 -$63,000.00 -$209,000.00
Net Investment Purchase and Sale -$159.32M -$410.95M -$14.36M -$21.96M -$96.54M
Financing Cash Flow $126.77M $663.04M $40.60M $298,000.00 $170.32M
Net Cash Flow from Continuing Financing Activities $126.77M $663.04M $40.60M $298,000.00 $170.32M
Net Issuance Payments Of Debt $0.00 – – -$109,000.00 $0.00
Net Common Stock Issuance $126.77M $4.37M $40.60M $671,000.00 $671,000.00
Net Preferred Stock Issuance $0.00 – – $0.00 $0.00
Ending Cash Balance $191.52M $268.47M $49.52M $46.94M $46.94M
Net Change in Cash -$76.95M $218.95M $2.59M -$44.32M -$14.64M
Beginning Cash Balance $268.47M $49.52M $46.94M $91.25M $61.58M
Free Cash Flow -$44.41M -$33.15M -$23.65M -$22.66M -$88.42M
Net Other Financing Charges – – – -$264,000.00 $169.64M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
-Gross PPE $3.10M $2.69M $2.01M $2.12M $2.12M
Investments and Advances $286.31M $252.02M $107.12M $142.54M $142.54M
-Available for Sale Securities $286.31M $252.02M $107.12M $142.54M $142.54M
Other Non-Current Assets $128,000.00 $128,000.00 $103,000.00 $103,000.00 $103,000.00
Total Liabilities $33.88M $24.85M $17.76M $16.69M $16.69M
Total Current Liabilities $31.78M $22.97M $16.63M $15.37M $15.37M
Payables $14.43M $7.95M $6.67M $4.16M $4.16M
-Accounts Payable $14.38M $7.95M $3.66M $4.16M $4.16M
-Due to Related Parties Current $50,000.00 $0.00 $3.00M $9,000.00 $9,000.00
Current Accrued Expenses $11.93M $11.42M $7.58M $5.33M $5.33M
Short-Term Debt and Capital Lease Obligation $838,000.00 $669,000.00 $680,000.00 $619,000.00 $619,000.00
Net PPE $3.10M $2.69M $2.01M $2.12M $2.12M
Total Non-Current Assets $289.53M $254.84M $109.23M $144.76M $144.76M
-Short Term Investments $728.76M $605.09M $339.31M $290.11M $290.11M
-Cash and Cash Equivalents $191.52M $268.47M $49.52M $46.94M $46.94M
-Current Capital Lease Obligation $838,000.00 $669,000.00 $680,000.00 $619,000.00 $619,000.00
Total Non-Current Liabilities $2.09M $1.88M $1.13M $1.31M $1.31M
Long Term Debt and Capital Lease Obligation $2.09M $1.88M $1.13M $1.31M $1.31M
-Long Term Capital Lease Obligation $2.09M $1.88M $1.13M $1.31M $1.31M
Total Equity $1.20B $1.11B $486.72M $471.93M $471.93M
Stockholders' Equity $1.20B $1.11B $486.72M $471.93M $471.93M
Capital Stock $2.09M $2.99M $2.98M $2.98M $2.98M
-Common Stock $67,000.00 $61,000.00 $50,000.00 $49,000.00 $49,000.00
-Preferred Stock $2.02M $2.93M $2.93M $2.93M $2.93M
Additional Paid-In Capital $1.51B $1.38B $705.20M $657.56M $657.56M
Gains/Losses Not Affecting Retained Earnings -$5.04M -$1.70M -$480,000.00 $546,000.00 $546,000.00
Retained Earnings -$312.15M -$262.18M -$220.98M -$189.16M -$189.16M
Total Assets $1.23B $1.14B $504.48M $488.62M $488.62M
Other Current Assets $21.22M $11.00M $6.42M $6.81M $6.81M
Total Current Assets $941.49M $884.56M $395.25M $343.86M $343.86M
Cash and Cash Equivalents & Short-Term Investments $920.28M $873.56M $388.83M $337.04M $337.04M
Convertible preferred securities – $2.93M $2.93M $0.00 $0.00

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Pretax Profit -$49.97M -$41.21M -$31.82M -$29.58M -$105.43M
Other Non-Operating Income (Expenses) $5,000.00 $4,000.00 $8,000.00 -$1,000.00 -$12,000.00
Other Income (Expense) $5,000.00 $4,000.00 $8,000.00 -$1,000.00 -$12,000.00
Non-Operating Interest Income $12.17M $8.90M $4.61M $4.85M $16.63M
Net Non-Operating Interest Income (Expense) $12.17M $8.90M $4.61M $4.85M $16.63M
Operating Profit -$62.14M -$50.11M -$36.43M -$34.43M -$122.05M
Research & Development $53.70M $43.26M $29.15M $27.64M $100.64M
-General & Admin Expense $8.44M $6.85M $7.29M $6.79M $21.41M
Selling and Admin Expenses $8.44M $6.85M $7.29M $6.79M $21.41M
Operating Expense $62.14M $50.11M $36.43M $34.43M $122.05M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$49.97M -$41.21M -$31.82M -$29.58M -$105.43M
Profit from Continuing Operations -$49.97M -$41.21M -$31.82M -$29.58M -$105.43M
Net Income to Parent Company -$49.97M -$41.21M -$31.82M -$29.58M -$105.43M
Diluted EPS -$0.63 -$0.55 -$0.48 -$0.45 -$1.85
Basic EPS -$0.63 -$0.55 -$0.48 -$0.45 -$1.85
Net Income to Common Stockholders -$49.97M -$41.21M -$31.82M -$29.58M -$105.43M
Non-Operating Interest Expense – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on ORKA.

Sign in to join the discussion.

Scroll to Top